Back to Search Start Over

Pheochromocytoma: An approach to diagnosis.

Authors :
Sbardella E
Grossman AB
Source :
Best practice & research. Clinical endocrinology & metabolism [Best Pract Res Clin Endocrinol Metab] 2020 Mar; Vol. 34 (2), pp. 101346. Date of Electronic Publication: 2019 Oct 22.
Publication Year :
2020

Abstract

Pheochromocytomas are rare neuroendocrine chromaffin-derived tumors that arise within the adrenal medulla. They are usually benign, but if not diagnosed or if left untreated, they can have devastating consequences. Clinical consideration of the diagnosis is paramount, as they may have protean manifestations, and a high index of suspicion is essential if serious consequences are to be avoided. An accurate biochemical diagnosis is crucial for the management of these patients: either plasma or urinary metanephrines are both highly sensitive and specific if correctly employed, but knowledge of pre- and post-analytic interference is essential. Diagnostic imaging with cross-sectional CT and/or MRI offers high sensitivity in their detection, but lack specificity. The introduction of PET/CT/MR has led to a dramatic improvement in the localization of both pheochromocytomas and paragangliomas, together with the increasing availability of new functional imaging radionuclides. Optimal investigation and accurate diagnosis is best achieved at 'centers of excellence' with expert multidisciplinary teams.<br /> (Copyright © 2019. Published by Elsevier Ltd.)

Details

Language :
English
ISSN :
1878-1594
Volume :
34
Issue :
2
Database :
MEDLINE
Journal :
Best practice & research. Clinical endocrinology & metabolism
Publication Type :
Academic Journal
Accession number :
31708376
Full Text :
https://doi.org/10.1016/j.beem.2019.101346